To identify the early events by which enhanced ChREBP transcriptional activity favor HCC development, bioinformatic analysis of transcriptomic datasets from liver overexpressing ChREBP for 3 weeks (pre-malignant model) and from ChREBP overexpressing tumors (malignant model) was performed. This evidence concerns the gene MLXIPL and hepatocellular carcinoma.